{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T03:02:45Z","timestamp":1789354965609,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:00:00Z","timestamp":1789257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:00:00Z","timestamp":1789257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"crossref","award":["TCMF-MP-114-01"],"award-info":[{"award-number":["TCMF-MP-114-01"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"uddhist Tzu Chi Medical Foundation","award":["TCMF-SP-115-01"],"award-info":[{"award-number":["TCMF-SP-115-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05391-y","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T13:49:44Z","timestamp":1789307384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcome of combined triamcinolone and platelet-rich plasma injection in treatment of patients with interstitial cystitis\/bladder pain syndrome"],"prefix":"10.1007","author":[{"given":"Jia-Fong","family":"Jhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ru","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,13]]},"reference":[{"issue":"1","key":"5391_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/nau.70112","volume":"45","author":"GT Werneburg","year":"2026","unstructured":"Werneburg GT, Moldwin R, Lowell Parsons C, Shivam Priyadarshi M, Sinha S, Quentin Clemens J (2026) Interstitial cystitis\/bladder pain syndrome (IC\/BPS) diagnosis: current limitations and a pragmatic clinical diagnostic definition. Neurourol Urodyn 45(1):32\u201338","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"5391_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/JU.0000000000002756","volume":"208","author":"JQ Clemens","year":"2022","unstructured":"Clemens JQ, Erickson DR, Varela NP, Lai HH (2022) Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J Urol 208(1):34\u201342","journal-title":"J Urol"},{"issue":"8","key":"5391_CR3","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/nau.24958","volume":"41","author":"AD Dobberfuhl","year":"2022","unstructured":"Dobberfuhl AD (2022) Pathophysiology, assessment, and treatment of overactive bladder symptoms in patients with interstitial cystitis\/bladder pain syndrome. Neurourol Urodyn 41(8):1958\u20131966","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"5391_CR4","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/nau.25310","volume":"43","author":"M Wyndaele","year":"2023","unstructured":"Wyndaele M, Charrua A, Herv\u00e9 F, Aronsson P, Grundy L, Khullar V, Wein A, Abrams P, Cruz F, Cruz CD (2023) Beyond the urothelium: interplay between autonomic nervous system and bladder inflammation in urinary tract infection, bladder pain syndrome with interstitial cystitis and neurogenic lower urinary tract dysfunction in spinal cord injury-ICI-RS 2023. Neurourol Urodyn 43(6):1283\u20131292","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"5391_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/17512433.2018.1457435","volume":"11","author":"T Ogawa","year":"2018","unstructured":"Ogawa T, Ishizuka O, Ueda T, Tyagi P, Chancellor MB, Yoshimura N (2018) Pharmacological management of interstitial cystitis\/bladder pain syndrome and the role cyclosporine and other immunomodulating drugs play. Expert Rev Clin Pharmacol 11(5):495\u2013505","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"5391_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/iju.14229","volume":"27","author":"Y Akiyama","year":"2020","unstructured":"Akiyama Y, Luo Y, Hanno PM, Maeda D, Homma Y (2020) Interstitial cystitis\/bladder pain syndrome: the evolving landscape, animal models and future perspectives. Int J Urol 27(6):491\u2013503","journal-title":"Int J Urol"},{"issue":"2","key":"5391_CR7","doi-asserted-by":"publisher","first-page":"E46","DOI":"10.5489\/cuaj.10134","volume":"6","author":"G Kaneko","year":"2012","unstructured":"Kaneko G, Nishimoto K, Ito Y, Uchida A (2012) The combination therapy of prednisolone and tacrolimus for severe painful bladder syndrome\/interstitial cystitis. Can Urol Assoc J 6(2):E46\u2013E49","journal-title":"Can Urol Assoc J"},{"key":"5391_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euros.2023.07.006","volume":"56","author":"Y Akiyama","year":"2023","unstructured":"Akiyama Y, Niimi A, Nomiya A, Taguchi S, Yamada Y, Sato Y, Yamada D, Maeda D, Ushiku T, Kume H, Homma Y (2023) Efficacy and safety of low-dose oral prednisolone for patients with refractory Hunner-type interstitial cystitis. Eur Urol Open Sci 56:1\u20138","journal-title":"Eur Urol Open Sci"},{"key":"5391_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.urology.2018.03.037","volume":"118","author":"MG Funaro","year":"2018","unstructured":"Funaro MG, King AN, Stern JNH, Moldwin RM, Bahlani S (2018) Endoscopic injection of low dose triamcinolone: a simple, minimally invasive, and effective therapy for interstitial cystitis with hunner lesions. Urology 118:25\u201329","journal-title":"Urology"},{"key":"5391_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/nau.70051","volume":"44","author":"HJ Jeong","year":"2025","unstructured":"Jeong HJ, Kang YJ, Choo MS, Jeong SJ, Oh SJ (2025) Transurethral fulguration of hunner lesion was effective for primary management of pelvic pain in patients with interstitial cystitis: a long-term follow-up study. Neurourol Urodyn 44:1047\u20131053","journal-title":"Neurourol Urodyn"},{"key":"5391_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96810-w","volume":"11","author":"YK Lee","year":"2021","unstructured":"Lee YK, Jhang JF, Jiang YH, Hsu YH, Ho HC, Kuo HC (2021) Difference in electron microscopic findings among interstitial cystitis\/bladder pain syndrome with distinct clinical and cystoscopic characteristics. Sci Rep 11:17258","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"5391_CR12","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.5213\/inj.2142100.050","volume":"26","author":"JF Jhang","year":"2022","unstructured":"Jhang JF, Jiang YH, Hsu YH, Ho HC, Birder LA, Lin TY et al (2022) Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in the patients with interstitial cystitis\/bladder pain syndrome after intravesical platelet-rich plasma injection. Int Neurourol J 26(Suppl 1):S57-67","journal-title":"Int Neurourol J"},{"key":"5391_CR13","first-page":"O42","volume":"11","author":"JF Jhang","year":"2019","unstructured":"Jhang JF, Wu SY, Lin TY, Kuo HC (2019) Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study. Low Urin Tract Symptoms 11:O42\u2013O47","journal-title":"Low Urin Tract Symptoms"},{"key":"5391_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/tcmj.tcmj_166_24","volume":"37","author":"WR Yu","year":"2025","unstructured":"Yu WR, Jiang YH, Jhang JF, Kuo HC (2025) Repeated intravesical injections of platelet-rich plasma are safe and effective in the treatment of interstitial cystitis\/bladder pain syndrome. Tzu Chi Med J 37:72\u201379","journal-title":"Tzu Chi Med J"},{"issue":"5","key":"5391_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.23736\/S2724-6051.25.06232-9","volume":"77","author":"HR Li","year":"2025","unstructured":"Li HR, Wang T, Shen SH, Peng L (2025) The efficacy and safety of intravesical platelet-rich plasma injections into the bladder for the treatment of interstitial cystitis\/bladder pain syndrome: a systematic review and meta-analysis. Minerva Urol Nephrol 77(5):605\u2013617","journal-title":"Minerva Urol Nephrol"},{"issue":"7","key":"5391_CR16","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s11255-025-04388-3","volume":"57","author":"YC Chiu","year":"2025","unstructured":"Chiu YC, Tsai PC, Jhang JF, Kuo HC (2025) Revealing distinct treatment mechanisms and outcome correlations in patients with interstitial cystitis\/bladder pain syndrome after different bladder therapies through urinary biomarker analysis. Int Urol Nephrol 57(7):2073\u20132080","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"5391_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/tcmj.tcmj_172_23","volume":"36","author":"WR Yu","year":"2024","unstructured":"Yu WR, Jiang YH, Jhang JF, Kuo HC (2024) Cystoscopic characteristic findings of interstitial cystitis and clinical implications. Tzu Chi Med J 36(1):30\u201337","journal-title":"Tzu Chi Med J"},{"issue":"7","key":"5391_CR18","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/nau.70107","volume":"44","author":"B Hayes","year":"2025","unstructured":"Hayes B, Namugosa M, Evans RJ, Hajebrahimi S, Janssen D, King C, Pandey S, Curtis Nickel J (2025) Patient related outcomes for interstitial cystitis\/bladder pain syndrome recommendations for clinical trials and general urology practice. Neurourol Urodyn 44(7):1455\u20131465","journal-title":"Neurourol Urodyn"},{"issue":"6 Suppl 1","key":"5391_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0090-4295(01)01126-8","volume":"57","author":"DP Lubeck","year":"2001","unstructured":"Lubeck DP, Whitmore K, Sant GR, Alvarez-Horine S, Lai C (2001) Psychometric validation of the O\u2019leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. Urology 57(6 Suppl 1):62\u201366","journal-title":"Urology"},{"key":"5391_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/iju.14585","volume":"28","author":"JF Jhang","year":"2021","unstructured":"Jhang JF, Jiang YH, Hsu YH, Ho HC, Kuo HC (2021) Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis\/bladder pain syndrome patients with Hunner\u2019s lesion and grade 3 glomerulation might be different from other types of patients. Int J Urol 28:823\u2013830","journal-title":"Int J Urol"},{"issue":"2","key":"5391_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15020121","volume":"15","author":"JF Jhang","year":"2023","unstructured":"Jhang JF, Yu WR, Kuo HC (2023) Comparison of the clinical efficacy and adverse events between intravesical injections of platelet-rich plasma and botulinum toxin A for the treatment of interstitial cystitis refractory to conventional treatment. Toxins (Basel) 15(2):121","journal-title":"Toxins (Basel)"},{"issue":"10","key":"5391_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41585-025-01044-4","volume":"22","author":"JF Jhang","year":"2025","unstructured":"Jhang JF, Yu WR, Jiang YH, Kuo HC (2025) Pathophysiology and potential multimodal therapeutic strategies for IC\/BPS. Nat Rev Urol 22(10):672\u2013686","journal-title":"Nat Rev Urol"},{"issue":"1","key":"5391_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-020-00597-3","volume":"20","author":"T Jiang","year":"2020","unstructured":"Jiang T, Zhou X, Chen Z, Xiong T, Fu J, Liu Z, Yan D, Zhou Z, Shen W (2020) Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II\/III interstitial cystitis\/bladder pain syndrome. BMC Urol 20(1):36","journal-title":"BMC Urol"},{"issue":"4","key":"5391_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/path.6353","volume":"264","author":"M Horie","year":"2024","unstructured":"Horie M, Akiyama Y, Katoh H, Taguchi S, Nakamura M, Mizuguchi K, Ito Y, Matsushita T, Ushiku T, Ishikawa S, Goto A, Kume H, Homma Y, Maeda D (2024) APRIL\/BAFF upregulation is associated with clonal B-cell expansion in Hunner-type interstitial cystitis. J Pathol 264(4):383\u2013395","journal-title":"J Pathol"},{"issue":"1","key":"5391_CR25","first-page":"25","volume":"34","author":"Y Akiyama","year":"2019","unstructured":"Akiyama Y, Homma Y, Maeda D (2019) Pathology and terminology of interstitial cystitis\/bladder pain syndrome: a review. Histol Histopathol 34(1):25\u201332","journal-title":"Histol Histopathol"},{"issue":"5","key":"5391_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051149","volume":"10","author":"WR Yu","year":"2022","unstructured":"Yu WR, Jiang YH, Jhang JF, Kuo HC (2022) Use of urinary cytokine and chemokine levels for identifying bladder conditions and predicting treatment outcomes in patients with interstitial cystitis\/bladder pain syndrome. Biomedicines (Basel) 10(5):1149","journal-title":"Biomedicines (Basel)"},{"issue":"4","key":"5391_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.urology.2007.11.055","volume":"71","author":"J Sairanen","year":"2008","unstructured":"Sairanen J, Hotakainen K, Tammela TL, Stenman UH, Ruutu M (2008) Urinary epidermal growth factor and interleukin-6 levels in patients with painful bladder syndrome\/interstitial cystitis treated with cyclosporine or pentosan polysulfate sodium. Urology 71(4):630\u2013633","journal-title":"Urology"},{"key":"5391_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-5-7","volume":"5","author":"CO Zhang","year":"2005","unstructured":"Zhang CO, Li ZL, Kong CZ (2005) APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis. BMC Urol 5:7","journal-title":"BMC Urol"},{"issue":"5","key":"5391_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12051093","volume":"12","author":"YH Jiang","year":"2022","unstructured":"Jiang YH, Jhang JF, Kuo HC (2022) Can we use urinary cytokine\/chemokine analysis in discriminating ulcer-type interstitial cystitis\/bladder pain syndrome? Diagnostics (Basel) 12(5):1093","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"5391_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.17219\/acem\/69231","volume":"27","author":"S Tonyali","year":"2018","unstructured":"Tonyali S, Ates D, Akbiyik F, Kankaya D, Baydar D, Ergen A (2018) Urine nerve growth factor (NGF) level, bladder nerve staining and symptom\/problem scores in patients with interstitial cystitis. Adv Clin Exp Med 27(2):159\u2013163","journal-title":"Adv Clin Exp Med"},{"issue":"3","key":"5391_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/path.6040","volume":"259","author":"JF Jhang","year":"2023","unstructured":"Jhang JF, Liu CD, Hsu YH, Chen CC, Chen HC, Jiang YH, Wu WC, Peng CW, Kuo HC (2023) EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis\/bladder pain syndrome with Hunner\u2019s lesion. J Pathol 259(3):276\u2013290","journal-title":"J Pathol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05391-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05391-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05391-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:02:49Z","timestamp":1789351369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05391-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,13]]},"references-count":31,"alternative-id":["5391"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05391-y","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,13]]},"assertion":[{"value":"6 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Ethics Committee of Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. IRB: 115-093-B, dated April 30, 2026.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":3,"name":"Ethics","label":"Permission to reproduce material from other sources","group":{"name":"EthicsHeading","label":"Declarations"}}]}}